| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Chief Technical Officer | Common Stock | 106,321 | $1,686,251 | $15.86 | 02 Jan 2026 | Direct |
| Janux Therapeutics, Inc. | Chief Technical Officer | Stock option (right to buy) | 100,100 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 02 Jan 2026 | 3 | -$32,966 | 4 | Chief Technical Officer | 02 Jan 2026, 21:00 |
| JANX | Janux Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Chief Technical Officer | 03 Jan 2025, 20:10 |
| JANX | Janux Therapeutics, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Chief Technical Officer | 03 Jan 2024, 16:54 |
| JANX | Janux Therapeutics, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Chief Technical Officer | 05 Jan 2023, 15:36 |
| JANX | Janux Therapeutics, Inc. | 01 Jan 2023 | 0 | $0 | 3/A | Chief Technical Officer | 03 Jan 2025, 20:01 |